Compare ATXG & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATXG | ACON |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 4.4M |
| IPO Year | N/A | 2022 |
| Metric | ATXG | ACON |
|---|---|---|
| Price | $0.34 | $3.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 62.5K | ★ 2.4M |
| Earning Date | 02-13-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,141,952.00 | $67,483.00 |
| Revenue This Year | N/A | $71.77 |
| Revenue Next Year | N/A | $80.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.91 |
| 52 Week Low | $0.28 | $3.55 |
| 52 Week High | $1.86 | $562.68 |
| Indicator | ATXG | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 39.52 | 35.20 |
| Support Level | $0.28 | $3.68 |
| Resistance Level | $0.39 | $3.75 |
| Average True Range (ATR) | 0.05 | 0.27 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 31.39 | 0.00 |
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.